Cervarixâ¢, GSK's cervical cancer vaccine, wins tender for UK national immunisation programme
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline's (GSK) cervical cancer vaccine, Cervarix TM, was confirmed as the UK Department of Health's vaccine of choice for its national human papillomavirus (HPV) immunisation programme.
Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
- Details
- Category: Pfizer
Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the worldâs most-prescribed cholesterol-lowering medicine.
Genzyme Files Applications for Approval of Mozobil in the United States and Europe
- Details
- Category: Genzyme
Genzyme Corporation (Nasdaq: GENZ) announced that it has submitted marketing applications in both the United States and the European Union for Mozobil™ (plerixafor), a product candidate intended to enhance mobilization of hematopoietic stem cells for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma.
AstraZeneca and Columbia University Medical Center Sign Strategic Research Collaboration
- Details
- Category: AstraZeneca
AstraZeneca and Columbia University Medical Center in New York announced that they have entered into a strategic research collaboration in metabolic related diseases, to develop novel therapeutics primarily in type 2 diabetes and obesity and, with a secondary focus on atherosclerosis (hardening of the arteries)/dyslipidaemia (abnormal blood lipid levels).
Romiplostim Data Show Potential Long-Term Efficacy and Safety
- Details
- Category: Amgen
Amgen Inc. (NASDAQ: AMGN) announced updated results from the ongoing, open-label extension study on the long-term safety and efficacy of romiplostim in adult patients with chronic immune thrombocytopenic purpura (ITP), a chronic and serious autoimmune disorder characterized by low platelet counts in the blood.
Pfizer Celebrates 5 Years of High-Impact Corporate Volunteer Missions
- Details
- Category: Pfizer
This summer, Maria Machado, a supply chain expert from Brazil, will make an extended visit to Africa â unlike any trip sheâs taken before. Maria and 15 of her colleagues at Pfizer, Inc. are part of a now 5-year-old skills-based corporate volunteerism program, the Pfizer Global Health Fellows.
Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.
- Details
- Category: Pfizer
Pfizer Inc (NYSE:PFE) announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ:ENCY) through a merger of Pfizerâs wholly-owned subsidiary, Explorer Acquisition Corp., with and into Encysive. Encysive is now a wholly-owned subsidiary of Pfizer.
More Pharma News ...
- First positive health technology assessments for novel oral anticoagulant Pradaxa®
- GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc.
- Nycomed sells oncology programs to 4SC
- Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research
- Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128
- Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR
- Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for DuoCover